Levitra

Wenning said Bayer wants to widen its health care unit and would consider making acquisitions to expand its over-the-counter drug lineup - providing that targets fit Bayer's business plan.

Wenning made the remark at a news conference when asked whether Bayer would bid for Pfizer's over-the-counter division, if it were put up for sale.

Pfizer said last month it might sell or spin off the unit.

Bayer's crop science division had a slight decline in sales of less than 1 percent to euro5.89 billion (US$7.07 billion) while its MaterialScience unit, which produces and sells plastics, reported growth of 24.4 percent to euro10.69 billion (US$12.8 billion) in 2005.

Shares of Bayer were down nearly 3.8 percent to euro32.52 (US$39.08) in Frankfurt trading.

- On the Net: http://www.bayer.com Copyright 2005, by The Associated Press.

All rights reserved.

This material may not be published, broadcast, rewritten or redistributed.

BW MALL SPONSORED LINKS Hot Stock Picks for Tomorrow Free report covering hot stock picks & tips, penny stocks, new issues, undervalued & undiscovered situations, and other aggressive stock ideas.

E-LOAN ® - Official Site Low Rate Mortgage, Home Equity, and Auto Loans.

Approval in Minutes.

No Lender fe...

Read more...